Emerging Therapies for Malignant Mesothelioma - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Emerging Therapies for Malignant Mesothelioma write by Nico van Zandwijk. This book was released on 2020-07-17. Emerging Therapies for Malignant Mesothelioma available in PDF, EPUB and Kindle.
Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Malignant Pleural Mesothelioma write by Takashi Nakano. This book was released on 2021-02-05. Malignant Pleural Mesothelioma available in PDF, EPUB and Kindle. This book provides essential information on recent advances in molecular genetics, epidemiology, translational research, and the latest results of clinical trials on mesothelioma. Significant progress has been made in understanding mesothelioma biology, and in developing new therapies for this refractory tumor, malignant pleural mesothelioma (MPM). Not only does this volume summarize the latest research-based data on the disease; it also shares insights into future research directions. The book consists of 5 themed sections on: epidemiology, pathogenesis, screening and early detection, molecular genetics, and clinical aspects and management. Several chapters focus on new trends in the field, e.g. immune therapy and identification of biomarkers, molecular oncogenesis including genetic susceptibility, and molecular diagnostic pathology. The book also highlights new cancer treatment approaches, such as immunotherapy based on immune checkpoint inhibitors, which has meant a paradigm shift in other types of cancer, and given some hope to MPM patients. In turn, it discusses recent molecular pathological studies on mesothelioma, which claim to offer more accurate classifications than traditional morphology and immunohistochemistry-based approaches. All of these cutting-edge analyses provide the basis for a closing discussion on future developments and research directions. Malignant Pleural Mesothelioma - Advances in Pathogenesis, Diagnosis, and Treatments has been edited and authored by respected researchers and will be of interest to medical, surgical and radiation oncologists; pulmonologists; pathologists and basic researchers alike. Since the disease represents a significant diagnostic and therapeutic challenge, scientists and clinicians from learners to experts, as well as fellows in training in these subspecialties, will value this book.
100 Questions & Answers About Mesothelioma
100 Questions & Answers About Mesothelioma - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook 100 Questions & Answers About Mesothelioma write by Harvey I. Pass. This book was released on 2009-06-11. 100 Questions & Answers About Mesothelioma available in PDF, EPUB and Kindle. Whether you're a newly diagnosed Mesothelioma patient, a survivor, or a friend or relative of either, this book offers help. The only book to provide the doctor's and patient's views, 100 Questions & Answers About Mesothelioma, Third Edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, legal options, and much more. This outstanding team of authors -- led by a world-class lung disease expert -- provides an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.
Malignant Mesothelioma
Malignant Mesothelioma - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Malignant Mesothelioma write by Harvey I. Pass. This book was released on 2006-08-01. Malignant Mesothelioma available in PDF, EPUB and Kindle. Malignant Mesothelioma brings together the most current diagnostic criteria and treatment plans from the world’s leading experts on this rare but devastating cancer. The first edition was a critical and commercial success and this revision builds on that reputation. The editors have brought together the world’s leading experts to fully explore the latest scientific breakthroughs in carcinogenesis, immunotherapy, potential vaccination strategies, and gene therapy. The clinical aspects of the book are equally strong, with thorough discussion of epidemiology, etiology, different clinical presentations, imaging (including interventional pulmonology), treatment of benign disease, strategies for multimodality treatment of malignant disease. Editors: Harvey I. Pass, M.D, Chief, Thoracic Surgery, New York University, New York, NY; Nicholas Vogelzang, M.D, Director, Nevada Cancer Institute, Las Vegas, NV; University of Chicago, Michele Carbone, M.D., Ph.D, Researcher and Director, Thoracic Oncology Program, Cancer Research Center of Hawaii, Honolulu, HI; and Anne S. Tsao, M.D, Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
Treatment of unresectable malignant pleural mesothelioma in 2021: emerging standards in immunotherapy
Treatment of unresectable malignant pleural mesothelioma in 2021: emerging standards in immunotherapy - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Treatment of unresectable malignant pleural mesothelioma in 2021: emerging standards in immunotherapy write by Bailey G. Fitzgerald. This book was released on 2021-08-05. Treatment of unresectable malignant pleural mesothelioma in 2021: emerging standards in immunotherapy available in PDF, EPUB and Kindle. Patients with unresectable malignant pleural mesothelioma (MPM) have historically poor outcomes and treatment, and their treatments have been limited to palliative chemotherapy. Recent efforts to improve prognosis for these patients by adding angiogenesis inhibitors to chemotherapy led to significant benefits. However, the emergence of immunotherapy combinations for the front-line treatment has upended the standard of care and has led to the first new FDA approvals for the treatment of MPM in nearly two decades. This review aims to cover the main clinical trials in unresectable MPM with VEGF inhibitors and immunotherapy which have led to paradigm shifts in current practice. Ongoing clinical trials exploring the combination of chemo and immunotherapies show a great deal of promise, and continued support for ambitious, large-scale well-designed trials remain vital for defining the future outcomes of patients diagnosed with MPM.
